New Evolution : China Blood Product Industry Report, 2012-2015 Available At MarketResearchReports.biz

Plasma is a key raw material of the blood product industry. In August 2011, China shut down 16 plasma stations in Guizhou, resulting in a decrease of 15% in the plasma volume of the year. However, due to the implementation of favorable policies, widening gap between supply and demand, rising product prices and other factors, more than 150 plasma stations in China produced about 3,600 tons of plasma in 2012, up 14.2% year on year. 

To Read The Complete Report with  TOC :  http://www.marketresearchreports.biz/analysis-details/china-blood-product-industry-report-2012-2015

From 2012 to mid-2013, new plasma stations of some Chinese enterprises have started plasma collection or obtained plasma collection permits, such as Yuechi plasma station of Jiangxi Boya Bio-Pharmaceutical, Changyuan plasma station of Hualan Bio, and Caoxian plasma station of China Biologic Products. It’s expected that China’s plasma supply tension will be further eased after 2013. 

TABLE OF CONTENT

1. Profile of Blood Products

1.1 Definition

1.2 Classification

1.3 Recombinant Blood Products

1.4 Industry Chain

1.5 Features

2. Overview of China Blood Products Industry

2.1 Market Size

2.2 Development Status

2.3 Supply & Demand

2.3.1 Supply 

2.3.2 Demand 

2.4 Market Competition

2.5 Operating Environment

2.5.1 International Market

2.5.2 Policies

2.5.3 Domestic Biopharmaceutical Market

2.6 Import & Export

To Buy a Copy Of This Report:   www.marketresearchreports.biz/analysis/170322  

3. Blood Product Market Segments in China

3.1 Human Albumin

3.1.1 Supply & Demand

3.1.2 Competition Pattern

3.1.3 Prospects

3.2 Human Immunoglobulin (pH4) for Intravenous Injection

3.2.1 Supply & Demand

3.2.2 Competition Pattern

3.3 Coagulation Factor VIII

3.3.1 Supply & Demand

3.3.2 Competition Pattern

3.3.3 Prospects

3.4 Hepatitis B Immunoglobulin

3.4.1 Supply & Demand

3.4.2 Competition Pattern

3.5 Human Immunoglobulin

3.5.1 Supply & Demand

3.5.2 Competition Pattern

3.6 Human Prothrombin Complex

3.6.1 Supply & Demand

3.6.2 Competition Pattern

3.7 Tetanus Immunoglobulin

3.7.1 Supply & Demand

3.7.2 Competition Pattern

3.8 Rabies Immunoglobulin

3.8.1 Supply & Demand

3.8.2 Competition Pattern

Contact

M/s Sheela

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-997-4948

Email: sales@marketresearchreports.biz

Website: http://www.marketresearchreports.biz/